These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
400 related articles for article (PubMed ID: 35435341)
1. The side effects of immune checkpoint inhibitor therapy on the endocrine system. Goyal I; Pandey MR; Sharma R; Chaudhuri A; Dandona P Indian J Med Res; 2021 Apr; 154(4):559-570. PubMed ID: 35435341 [TBL] [Abstract][Full Text] [Related]
2. Immune Checkpoint Inhibitors-Induced Endocrinopathies: Assessment, Management and Monitoring in a Comprehensive Cancer Centre. Elshafie O; Khalil AB; Salman B; Atabani A; Al-Sayegh H Endocrinol Diabetes Metab; 2024 Jul; 7(4):e00505. PubMed ID: 38932429 [TBL] [Abstract][Full Text] [Related]
3. Endocrine side effects induced by immune checkpoint inhibitors. Corsello SM; Barnabei A; Marchetti P; De Vecchis L; Salvatori R; Torino F J Clin Endocrinol Metab; 2013 Apr; 98(4):1361-75. PubMed ID: 23471977 [TBL] [Abstract][Full Text] [Related]
4. Endocrine and metabolic adverse effects of immune checkpoint inhibitors: an overview (what endocrinologists should know). Ruggeri RM; Campennì A; Giuffrida G; Trimboli P; Giovanella L; Trimarchi F; Cannavò S J Endocrinol Invest; 2019 Jul; 42(7):745-756. PubMed ID: 30471004 [TBL] [Abstract][Full Text] [Related]
5. Endocrine toxicities of immune checkpoint inhibitors. Wright JJ; Powers AC; Johnson DB Nat Rev Endocrinol; 2021 Jul; 17(7):389-399. PubMed ID: 33875857 [TBL] [Abstract][Full Text] [Related]
6. Endocrine side effects of immune checkpoint inhibitors. Cardona Z; Sosman JA; Chandra S; Huang W Front Endocrinol (Lausanne); 2023; 14():1157805. PubMed ID: 37251665 [TBL] [Abstract][Full Text] [Related]
7. Endocrine toxicity of immune checkpoint inhibitors: a real-world study leveraging US Food and Drug Administration adverse events reporting system. Zhai Y; Ye X; Hu F; Xu J; Guo X; Zhuang Y; He J J Immunother Cancer; 2019 Nov; 7(1):286. PubMed ID: 31694698 [TBL] [Abstract][Full Text] [Related]
8. Immune Checkpoint Inhibitors and Endocrine Disorders: A Position Statement from the Korean Endocrine Society. Kwon H; Roh E; Ahn CH; Kim HK; Ku CR; Jung KY; Lee JH; Kim EH; Suh S; Hong S; Ha J; Moon JS; Kim JH; Kim MK; Endocrinol Metab (Seoul); 2022 Dec; 37(6):839-850. PubMed ID: 36604955 [TBL] [Abstract][Full Text] [Related]
10. Endocrine Adverse Events Caused by Different Types and Different Doses of Immune Checkpoint Inhibitors in the Treatment of Solid Tumors: A Meta-Analysis and Systematic Review. Yang Y; Liu J; Yang K; Ma Y; Fu S; Tang X; Wang Y; Zhou L J Clin Pharmacol; 2021 Mar; 61(3):282-297. PubMed ID: 33345342 [TBL] [Abstract][Full Text] [Related]
14. How we treat endocrine complications of immune checkpoint inhibitors. Paschou SA; Stefanaki K; Psaltopoulou T; Liontos M; Koutsoukos K; Zagouri F; Lambrinoudaki I; Dimopoulos MA ESMO Open; 2021 Feb; 6(1):100011. PubMed ID: 33399077 [TBL] [Abstract][Full Text] [Related]
15. Incidence of Endocrine Dysfunction Following the Use of Different Immune Checkpoint Inhibitor Regimens: A Systematic Review and Meta-analysis. Barroso-Sousa R; Barry WT; Garrido-Castro AC; Hodi FS; Min L; Krop IE; Tolaney SM JAMA Oncol; 2018 Feb; 4(2):173-182. PubMed ID: 28973656 [TBL] [Abstract][Full Text] [Related]
16. Endocrine Toxicity of Cancer Immunotherapy Targeting Immune Checkpoints. Chang LS; Barroso-Sousa R; Tolaney SM; Hodi FS; Kaiser UB; Min L Endocr Rev; 2019 Feb; 40(1):17-65. PubMed ID: 30184160 [TBL] [Abstract][Full Text] [Related]
17. Management of endocrine immune-related adverse events of immune checkpoint inhibitors: an updated review. Stelmachowska-Banaś M; Czajka-Oraniec I Endocr Connect; 2020 Oct; 9(10):R207-R228. PubMed ID: 33064663 [TBL] [Abstract][Full Text] [Related]
18. Clinical Characteristics, Management, and Potential Biomarkers of Endocrine Dysfunction Induced by Immune Checkpoint Inhibitors. Iwama S; Kobayashi T; Arima H Endocrinol Metab (Seoul); 2021 Apr; 36(2):312-321. PubMed ID: 33934588 [TBL] [Abstract][Full Text] [Related]
19. Immune checkpoint inhibitor-related hypophysitis. Mizukoshi T; Fukuoka H; Takahashi Y Best Pract Res Clin Endocrinol Metab; 2022 May; 36(3):101668. PubMed ID: 35562229 [TBL] [Abstract][Full Text] [Related]
20. Endocrine immune-related adverse events by immune checkpoint inhibitors and potential predictive markers: a prospective study from a single tertiary center. Barlas T; Sutcuoglu O; Akdogan O; Balos Toruner F; Akturk M; Ozdemir N; Yazici O; Eroglu Altinova A Endocr Relat Cancer; 2024 Nov; 31(11):. PubMed ID: 39194584 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]